BioSpace News Archive

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by AstraZeneca to be a specialty pharmacy partner for KOSELUGO™ (selumetinib), a novel oral kinase inhibitor indicated for the treatment of pediatric patients aged two years and above, with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. “The approval of KOSELUGO represents a new treatment st

Lantheus Holdings, Inc. today announced that Lantheus has entered into a Support Agreement (the “Support Agreement”) with Velan Capital (“Velan”) in connection with the proposed merger of Lantheus and Progenics.

Five Prime Therapeutics, Inc. today announced the appointment of Thomas Civik as President and Chief Executive Officer and a member of the Board of Directors of the company. Mr. Civik joins Five Prime from

54gene , the African genomics research, services, and development company has closed a Series A round of $15M , led by Adjuvant Capita l , a life sciences fund backed

Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for the development of antibody tests for COVID-19. Since the emergence of COVID-19 outbreaks in January, Meridian has supported molecular diagnostic companies with critical master mixes and enzymes for their COVID-19 Molecular Diagnostics tests. To meet the massive need for antibody testing, Meridian has now launched a series of

Research shows viruses are killed by exposure to Vomaris Bioelectric V.Dox ™ Technology

Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced today that its immuno-supportive/anti-oxidant complex, labeled acuMMUNETM (trademark registration pending), is now commercially availabl

Launching today, Vault Health, a startup specializing in healthcare for men, has turned focus to help fulfill demand for hard to get COVID-19 tests in 48 states by working with RUCDR Infinite Biologics to provide a first-of-its-kind FDA EUA-approved saliva test for COVID-19.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of their Pharma Research Solutions, the latest expansion of the company’s portfolio of comprehensive genomics assays and analytics

Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates